2 CASES OF GASTRIC-CANCER REMARKABLY REDUCED WITH A COMBINED DOSAGE OF IRSOGLADINE MALEATE PREPARATION AND UFT

Authors
HOSOKAWA T OGAWA K OTANI Y KAJIWARA T
Citation
T. Hosokawa et al., 2 CASES OF GASTRIC-CANCER REMARKABLY REDUCED WITH A COMBINED DOSAGE OF IRSOGLADINE MALEATE PREPARATION AND UFT, Oncology Reports, 1(1), 1994, pp. 93-95
Citations number
7
Categorie Soggetti
Oncology
Journal title
Oncology Reports → ACNP
ISSN journal
1021335X
Volume
1
Issue
1
Year of publication
1994
Pages
93 - 95
Database
ISI
SICI code
1021-335X(1994)1:1<93:2COGRR>2.0.ZU;2-P
Abstract
Irsogladine Maleate intensifies the degree of intercellular contact so we expected that a combination of Irsogladine Maleate and UFT would c ause tumor-reducing effect and normalization of the malignant cells. A combination of Irsogladine Maleate and UFT was administered to 2 pati ents with inoperable gastric cancer (Case 1: An 83-year-old male: Borr mann type I, Case 2: A 93-year-old female: A relatively wide early gas tric cancer), marked tumor reduction was obtained in both cases. The d oses administered were 4 mg/day of Irsogladine Maleate and 200 mg/day of UFT.